A quantitative, Bayesian-informed approach to gene-specific variant classification: Updated Expert Panel recommendations improve classification of TP53 germline variants for Li-Fraumeni syndrome.
Genome Med.
2025 Oct 22;17(1):128. doi: 10.1186/s13073-025-01536-3. Review. PubMed PMID:
41126324; PubMed Central PMCID:
PMC12548217.
Germline whole-exome sequencing reveals FOXP3-related gene variants conferring urinary cancer susceptibility and associated with immune escape.
J Immunother Cancer.
2025 Sep 16;13(9). doi: 10.1136/jitc-2024-010417. PubMed PMID:
40962358; PubMed Central PMCID:
PMC12443205.
Assessing MC1R Variants in Lentigo Maligna Melanoma within the Utah Population.
Cancer Res Commun.
2025 Jul 1;5(7):1228-1234. doi: 10.1158/2767-9764.CRC-25-0263. PubMed PMID:
40673485; PubMed Central PMCID:
PMC12301710.
Integration of protein stability and AlphaMissense scores improves bioinformatic impact prediction for p53 missense and in-frame amino acid deletion variants.
Am J Hum Genet.
2025 May 1;112(5):1003-1014. doi: 10.1016/j.ajhg.2025.01.012. Epub 2025 Apr 14. PubMed PMID:
40233742; PubMed Central PMCID:
PMC12120181.
Functional Characterization of a Genetic Variant in the 5' UTR of APC 1B Promoter in a Familial Adenomatous Polyposis Family.
Am J Med Genet A.
2025 Jul;197(7):e63992. doi: 10.1002/ajmg.a.63992. Epub 2025 Mar 10. PubMed PMID:
40062631.
Exome Sequencing for Head and Neck Cancer Predisposition Genes.
medRxiv.
2025 Jan 22;. doi: 10.1101/2025.01.20.25320626. PubMed PMID:
39973998; PubMed Central PMCID:
PMC11838995.
Using gene and gene-set association tests to identify lethal prostate cancer genes.
Prostate Cancer Prostatic Dis.
2025 Jun;28(2):490-495. doi: 10.1038/s41391-024-00879-z. Epub 2024 Aug 17. PubMed PMID:
39154125.
Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel.
Am J Hum Genet.
2024 Sep 5;111(9):2044-2058. doi: 10.1016/j.ajhg.2024.07.013. Epub 2024 Aug 13. PubMed PMID:
39142283; PubMed Central PMCID:
PMC11393667.
Atypical cancer risk profile in carriers of Italian founder BRCA1 variant p.His1673del: Implications for classification and clinical management.
Cancer Med.
2024 Aug;13(16):e70114. doi: 10.1002/cam4.70114. PubMed PMID:
39194334; PubMed Central PMCID:
PMC11350839.
Inherited Germline Variants in Urinary Tract Cancer: A Multicenter Whole-Exome Sequencing Analysis and Correlation With Clinical Features and Tumor Genomics.
JCO Precis Oncol.
2024 Jun;8:e2300697. doi: 10.1200/PO.23.00697. PubMed PMID:
38976819; PubMed Central PMCID:
PMC11813167.
Measuring Psoriasis Severity at Home.
J Vis Exp.
2024 Mar 1;(205). doi: 10.3791/66065. PubMed PMID:
38497631.
Cancer Risks Associated With TP53 Pathogenic Variants: Maximum Likelihood Analysis of Extended Pedigrees for Diagnosis of First Cancers Beyond the Li-Fraumeni Syndrome Spectrum.
JCO Precis Oncol.
2024 Feb;8:e2300453. doi: 10.1200/PO.23.00453. PubMed PMID:
38412388; PubMed Central PMCID:
PMC10914239.
PAPRIKA: A Question Bank for Assessing Psoriatic Arthritis Risk in Individuals of Diverse Ancestries.
Arthritis Care Res (Hoboken).
2024 Mar;76(3):421-425. doi: 10.1002/acr.25232. Epub 2024 Jan 20. PubMed PMID:
37691268.
A likelihood ratio approach for utilizing case-control data in the clinical classification of rare sequence variants: application to BRCA1 and BRCA2.
Hum Mutat.
2023;2023. doi: 10.1155/2023/9961341. Epub 2023 Sep 14. PubMed PMID:
38725546; PubMed Central PMCID:
PMC11080979.
Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3/BP4 criteria.
Am J Hum Genet.
2022 Dec 1;109(12):2163-2177. doi: 10.1016/j.ajhg.2022.10.013. Epub 2022 Nov 21. PubMed PMID:
36413997; PubMed Central PMCID:
PMC9748256.
Clinical, splicing, and functional analysis to classify BRCA2 exon 3 variants: Application of a points-based ACMG/AMP approach.
Hum Mutat.
2022 Dec;43(12):1921-1944. doi: 10.1002/humu.24449. Epub 2022 Oct 23. PubMed PMID:
35979650; PubMed Central PMCID:
PMC10946542.
Uncovering the Contribution of Moderate-Penetrance Susceptibility Genes to Breast Cancer by Whole-Exome Sequencing and Targeted Enrichment Sequencing of Candidate Genes in Women of European Ancestry.
Cancers (Basel).
2022 Jul 11;14(14). doi: 10.3390/cancers14143363. PubMed PMID:
35884425; PubMed Central PMCID:
PMC9317824.
Psoriasis Characteristics for the Early Detection of Psoriatic Arthritis.
J Rheumatol.
2021 Oct;48(10):1559-1565. doi: 10.3899/jrheum.201123. Epub 2021 Apr 15. PubMed PMID:
33858978; PubMed Central PMCID:
PMC8487898.
Specifications of the ACMG/AMP variant interpretation guidelines for germline TP53 variants.
Hum Mutat.
2021 Mar;42(3):223-236. doi: 10.1002/humu.24152. Epub 2020 Dec 25. PubMed PMID:
33300245; PubMed Central PMCID:
PMC8374922.
Considerations in assessing germline variant pathogenicity using cosegregation analysis.
Genet Med.
2020 Dec;22(12):2052-2059. doi: 10.1038/s41436-020-0920-4. Epub 2020 Aug 10. PubMed PMID:
32773770.
Pathogenic Germline DNA Repair Gene and HOXB13 Mutations in Men With Metastatic Prostate Cancer.
JCO Precis Oncol.
2020;4. doi: 10.1200/PO.19.00284. eCollection 2020. PubMed PMID:
32923906; PubMed Central PMCID:
PMC7446531.
Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing.
J Natl Cancer Inst.
2018 Aug 1;110(8):855-862. doi: 10.1093/jnci/djy106. PubMed PMID:
30099541; PubMed Central PMCID:
PMC6093350.
Germline mutations in PPFIBP2 are associated with lethal prostate cancer.
Prostate.
2018 Dec;78(16):1222-1228. doi: 10.1002/pros.23697. Epub 2018 Jul 24. PubMed PMID:
30043417.
Comprehensive annotation of BRCA1 and BRCA2 missense variants by functionally validated sequence-based computational prediction models.
Genet Med.
2019 Jan;21(1):71-80. doi: 10.1038/s41436-018-0018-4. Epub 2018 Jun 8. PubMed PMID:
29884841; PubMed Central PMCID:
PMC6287763.
Improved, ACMG-compliant, in silico prediction of pathogenicity for missense substitutions encoded by TP53 variants.
Hum Mutat.
2018 Aug;39(8):1061-1069. doi: 10.1002/humu.23553. Epub 2018 Jun 5. PubMed PMID:
29775997; PubMed Central PMCID:
PMC6043381.
Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
JAMA Oncol.
2017 Sep 1;3(9):1190-1196. doi: 10.1001/jamaoncol.2017.0424. PubMed PMID:
28418444; PubMed Central PMCID:
PMC5599323.
Evolutionary selected Tibetan variants of HIF pathway and risk of lung cancer.
Oncotarget.
2017 Feb 14;8(7):11739-11747. doi: 10.18632/oncotarget.14340. PubMed PMID:
28036300; PubMed Central PMCID:
PMC5355300.
PERCH: A Unified Framework for Disease Gene Prioritization.
Hum Mutat.
2017 Mar;38(3):243-251. doi: 10.1002/humu.23158. Epub 2017 Jan 28. PubMed PMID:
27995669; PubMed Central PMCID:
PMC5299048.
Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFab.
Genet Med.
2017 Jan;19(1):30-35. doi: 10.1038/gim.2016.43. Epub 2016 May 12. PubMed PMID:
27171545; PubMed Central PMCID:
PMC5107177.
Multigene testing of moderate-risk genes: be mindful of the missense.
J Med Genet.
2016 Jun;53(6):366-76. doi: 10.1136/jmedgenet-2015-103398. Epub 2016 Jan 19. PubMed PMID:
26787654; PubMed Central PMCID:
PMC4893078.
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.
J Natl Cancer Inst.
2016 Feb;108(2). doi: 10.1093/jnci/djv315. Print 2016 Feb. PubMed PMID:
26586665; PubMed Central PMCID:
PMC4907358.
Targeted massively parallel sequencing of a panel of putative breast cancer susceptibility genes in a large cohort of multiple-case breast and ovarian cancer families.
J Med Genet.
2016 Jan;53(1):34-42. doi: 10.1136/jmedgenet-2015-103452. Epub 2015 Nov 3. PubMed PMID:
26534844; PubMed Central PMCID:
PMC4915734.
A homozygous PMS2 founder mutation with an attenuated constitutional mismatch repair deficiency phenotype.
J Med Genet.
2015 May;52(5):348-52. doi: 10.1136/jmedgenet-2014-102934. Epub 2015 Feb 17. PubMed PMID:
25691505.
An epidemiologic review of marijuana and cancer: an update.
Cancer Epidemiol Biomarkers Prev.
2015 Jan;24(1):15-31. doi: 10.1158/1055-9965.EPI-14-1026. Review. PubMed PMID:
25587109; PubMed Central PMCID:
PMC4302404.
Estimation of the RNU2 macrosatellite mutation rate by BRCA1 mutation tracing.
Nucleic Acids Res.
2014 Aug;42(14):9121-30. doi: 10.1093/nar/gku639. Epub 2014 Jul 17. PubMed PMID:
25034697; PubMed Central PMCID:
PMC4132748.
Rare mutations in RINT1 predispose carriers to breast and Lynch syndrome-spectrum cancers.
Cancer Discov.
2014 Jul;4(7):804-15. doi: 10.1158/2159-8290.CD-14-0212. Epub 2014 May 2. PubMed PMID:
25050558; PubMed Central PMCID:
PMC4234633.
COMPLEXO: identifying the missing heritability of breast cancer via next generation collaboration.
Breast Cancer Res.
2013 Jun 21;15(3):402. doi: 10.1186/bcr3434. PubMed PMID:
23809231; PubMed Central PMCID:
PMC3706918.
Familial prostate cancer: the damage done and lessons learnt.
Nat Rev Urol.
2013 Feb;10(2):116-22. doi: 10.1038/nrurol.2012.257. Epub 2013 Jan 15. PubMed PMID:
23318356; PubMed Central PMCID:
PMC3913476.
Descriptive, environmental and genetic epidemiology of nasopharyngeal carcinoma.
In:
Busson P, editor.
Nasopharyngeal Carcinoma
New York: Springer and Landes Bioscience; 2012.
Haplotype analysis and ancient origin of the BRCA1 c.4035delA Baltic founder mutation.
Eur J Med Genet.
2013 Mar;56(3):125-30. doi: 10.1016/j.ejmg.2012.12.007. Epub 2012 Dec 27. PubMed PMID:
23274591.
Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity.
Nat Genet.
2012 Dec;44(12):1341-8. doi: 10.1038/ng.2467. Epub 2012 Nov 11. PubMed PMID:
23143594; PubMed Central PMCID:
PMC3510312.
Calibration of multiple in silico tools for predicting pathogenicity of mismatch repair gene missense substitutions.
Hum Mutat.
2013 Jan;34(1):255-65. doi: 10.1002/humu.22214. Epub 2012 Oct 22. PubMed PMID:
22949387; PubMed Central PMCID:
PMC4318556.
BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer risk.
J Med Genet.
2012 Aug;49(8):525-32. doi: 10.1136/jmedgenet-2012-101037. PubMed PMID:
22889855; PubMed Central PMCID:
PMC3810416.
Haplotype analysis of the 185delAG BRCA1 mutation in ethnically diverse populations.
Eur J Hum Genet.
2013 Feb;21(2):212-6. doi: 10.1038/ejhg.2012.124. Epub 2012 Jul 4. PubMed PMID:
22763381; PubMed Central PMCID:
PMC3548269.
Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis.
Am J Hum Genet.
2012 May 4;90(5):796-808. doi: 10.1016/j.ajhg.2012.03.013. Epub 2012 Apr 19. PubMed PMID:
22521419; PubMed Central PMCID:
PMC3376540.
A review of the clinical phenotype of 254 patients with genetically confirmed pachyonychia congenita.
J Am Acad Dermatol.
2012 Oct;67(4):680-6. doi: 10.1016/j.jaad.2011.12.009. Epub 2012 Jan 20. PubMed PMID:
22264670.
Design considerations for massively parallel sequencing studies of complex human disease.
PLoS One.
2011;6(8):e23221. doi: 10.1371/journal.pone.0023221. Epub 2011 Aug 5. PubMed PMID:
21850262; PubMed Central PMCID:
PMC3151293.
On the origin and diffusion of BRCA1 c.5266dupC (5382insC) in European populations.
Eur J Hum Genet.
2011 Mar;19(3):300-6. doi: 10.1038/ejhg.2010.203. Epub 2010 Dec 1. PubMed PMID:
21119707; PubMed Central PMCID:
PMC3062007.
Traditional Cantonese diet and nasopharyngeal carcinoma risk: a large-scale case-control study in Guangdong, China.
BMC Cancer.
2010 Aug 20;10:446. doi: 10.1186/1471-2407-10-446. PubMed PMID:
20727127; PubMed Central PMCID:
PMC2931495.
Carriers of rare missense variants in IFIH1 are protected from psoriasis.
J Invest Dermatol.
2010 Dec;130(12):2768-72. doi: 10.1038/jid.2010.214. Epub 2010 Jul 29. PubMed PMID:
20668468; PubMed Central PMCID:
PMC3680368.
What would you like to do?